ROSM

What ROSM does

ROSM (Regenerative Orthopedics and Sports Medicine) is a private, Washington, D.C.-based medical practice founded in 2014 that specializes in regenerative orthopedics and sports medicine. The practice treats osteoarthritis, sports injuries, and related musculoskeletal conditions using orthobiologic therapies including platelet-rich plasma (PRP), stem cell therapy, and an investigational adipose tissue allograft currently being studied in a clinical trial supported by a $1 million grant from the Maryland Stem Cell Research Fund. ROSM employs between 11 and 50 staff and operates primarily through direct patient care in a single regional market, with a secondary footprint in physician training and clinical research.

The practice is co-founded and led by Dr. Sean Mulvaney and Dr. John Ferrell, both recognized leaders in regenerative medicine. Dr. Mulvaney was elected President-Elect of the American Academy of Orthopaedic Medicine (AAOM) and received AAOM's Lifetime Achievement Award in 2026, and the pair were featured instructors at AAOM's OTX26 conference where they trained more than 300 physicians globally in advanced orthobiologic techniques.

ROSM generates revenue from medical practice services, including consultations, diagnostics, and therapeutic procedures (professional services pricing, not publicly disclosed), supplemented by clinical trial site fees and grant funding. Its go-to-market relies on physician referrals, clinical trial participation, and thought-leadership positioning through professional organizations such as AAOM, rather than direct-to-consumer marketing. Customer segments include osteoarthritis patients seeking disease-modifying therapies, athletes and active individuals with sports injuries, and physicians seeking continuing education in regenerative orthopedics.

Name

ROSM

Legal name

Regenerative Orthopedics and Sports Medicine

Website

https://rosm.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

ROSM is a Washington-based regenerative orthopedics practice offering PRP, stem cell, and investigational adipose tissue allograft therapies for osteoarthritis and sports injuries, serving patients and training physicians globally under recognized clinical leadership.

Ownership category

akta.pro rank

Product category

Regenerative Orthopedics and Sports Medicine

NAICS

Offices of Podiatrists (621391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

General Orthopedics (HLAKALAA)

akta.pro secondary industry

Foot & Ankle (HLAKALAG)

Keywords

• Regenerative orthopedics
• Orthobiologic treatments
• Sports medicine
• PRP therapy
• Stem cell therapy

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Services: ROSM serves as a clinical trial site for regenerative therapies, receiving grant funding ($1M from Maryland Stem Cell Research Fund) for investigating new osteoarthritis treatments
2. Medical Practice Services: Provides regenerative orthopedics and sports medicine treatments to patients, likely including consultation, diagnostic, and therapeutic services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

ROSM is a regenerative orthopedics and sports medicine practice that delivers orthobiologic treatments—PRP (Platelet-Rich Plasma) therapy, stem cell therapy, and an investigational Adipose Tissue Allograft therapy for osteoarthritis—to individual patients. The practice also operates as a clinical trial site for novel regenerative therapies and runs physician training programs in advanced orthobiologic techniques.

Product overview

ROSM (Regenerative Orthopedics and Sports Medicine) is a medical practice offering regenerative medicine treatments. The practice provides a portfolio of orthobiologic treatments centered on PRP (Platelet-Rich Plasma) therapy, stem cell therapy, and Adipose Tissue Allograft. These services are designed to treat orthopedic conditions and sports injuries through tissue regeneration rather than traditional surgical interventions.

Differentiator

Problem solved

Functional benefit

Products and services

• PRP (Platelet-Rich Plasma) Therapy
• Stem Cell Therapy
• Adipose Tissue Allograft Therapy
• Physician Training Programs

Quantifiable outcome

• Training 300+ physicians globally in regenerative techniques

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• American Academy of Orthopaedic Medicine (AAOM)flagshipStrategic or Co-development Partner · 18 March 2026AAOM selected ROSM co-founders as featured instructors at OTX26 conference and recognized Dr. Mulvaney as President-Elect with Lifetime Achievement Award, demonstrating deep professional organization partnership.
• BritecytecoreStrategic or Co-development Partner · 30 December 2025Britecyte is collaborating with ROSM as part of a clinical trial investigating a new therapy for osteoarthritis. The trial aims to explore a potential disease-reversing treatment using Adipose Tissue Allograft.
• AmarexcoreStrategic or Co-development Partner · 30 December 2025Amarex is involved with ROSM in a clinical trial for osteoarthritis treatment. The partnership is focused on developing a potential disease-reversing therapy using Adipose Tissue Allograft, supported by a $1M grant.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Regenexx: Regenexx is the largest U.S. network specializing in interventional regenerative orthopedics, offering PRP and stem cell treatments for orthopedic conditions. It is the most direct competitor to ROSM in the regenerative orthobiologics space, sharing the same core therapeutic modalities and disease-reversing positioning.
• Centeno-Schultz Clinic: Centeno-Schultz Clinic is a regenerative medicine and interventional orthopedics practice pioneering image-guided PRP and stem cell therapies. It overlaps directly with ROSM on orthobiologic modalities, physician training programs, and osteoarthritis treatment focus.
• Steadman Clinic: Steadman Clinic is a leading orthopedic and sports medicine specialty practice delivering advanced, non-surgical and surgical treatments to athletes and active patients. Comparable to ROSM in clinical specialty and patient demographic, though it offers a broader surgical mix.
• Andrews Sports Medicine & Orthopaedic Center: Andrews Sports Medicine is a specialty orthopedic practice focused on sports medicine and regenerative treatments for professional and amateur athletes. Comparable to ROSM in sports medicine focus, though larger scale with broader surgical capability.
• Kerlan-Jobe Orthopaedic Clinic: Kerlan-Jobe is a specialty orthopedic and sports medicine practice with deep expertise in treating professional athletes. Comparable to ROSM in regenerative orthopedics and sports medicine focus, though with greater surgical orientation and franchise scale.

Broad incumbents

• Hospital for Special Surgery (HSS): HSS is the leading U.S. specialty hospital for orthopedics and rheumatology, offering the full spectrum of orthopedic care including regenerative therapies. It is a broad incumbent that competes with ROSM for complex orthopedic cases and sports medicine patients at much greater scale.
• Rothman Orthopaedic Institute: Rothman is a large multi-site orthopedic specialty practice spanning sports medicine, joint replacement, and regenerative treatments. Comparable to ROSM in clinical focus but operates at substantially larger geographic and patient scale across the Eastern U.S.
• Cleveland Clinic Orthopaedic & Rheumatologic Institute: Cleveland Clinic's orthopedic institute is a major destination for complex musculoskeletal care including regenerative medicine offerings. It is a broad incumbent competing with ROSM for high-acuity and sports medicine patients, with vastly greater resources and brand.

Regional players

• Ortho Illinois: Ortho Illinois is a multi-specialty orthopedic practice serving the Midwest with sports medicine, joint replacement, and regenerative options. Comparable in clinical scope to ROSM but operating in a different geographic market with broader surgical services.

Others

• BioBridge Global / StemBioPure: BioBridge Global and adjacent entities supply allograft and cell-based tissue products used in regenerative orthopedics. Relevant as an ecosystem partner/supplier rather than a direct competitor, comparable to ROSM through its Adipose Tissue Allograft clinical trial dependency on similar supply chains.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ROSMROCKS
• Facebookfacebook.com/ROSMonline
• LinkedInlinkedin.com/company/regenerative-orthopedics-and-sports-medicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ROSM